• Lubricating And Downsizing Endotracheal Tubes

    Lubricating And Downsizing Endotracheal Tubes

    After endotracheal intubation for a general anesthetic, it is not uncommon for patients to report a sore throat in the recovery area. Although it’s usually self-limited, small details in airway management can often shape a patient’s overall satisfaction with their perioperative care. In appropriate patients, I will downsize the endotracheal…

    Read More

  • Extubating Patients In The CVICU

    Extubating Patients In The CVICU

    This video walks through how I approach extubation for many of my postoperative patients in the CVICU, drawing directly from the same physiologic framework I use as a cardiac anesthesiologist in the operating room. View this post on Instagram A post shared by Rishi Kumar, MD | RK.MD (@rishimd)

    Read More

  • Cold Weather And Aortic Dissection

    Cold Weather And Aortic Dissection

    Chronic hypertension, medial degeneration, elastic fiber fragmentation, smooth muscle cell loss, and progressive aortic dilation are all mechanisms implicated in acute aortic dissection (AAD). Although cold weather does not create medial degeneration, it can precipitate issues in an already compromised aorta. Population-level data consistently show winter peaks in acute aortic…

    Read More

  • Maintenance of Certification in Anesthesiology (MOCA)

    Maintenance of Certification in Anesthesiology (MOCA)

    Maintenance of certification in anesthesiology (MOCA) evolved from an exam taken every decade to now having to complete 30 online questions every quarter, maintain an unrestricted license to practice medicine, obtain 250 category 1 continuing medical education (CME) credits (20 of which are approved as “patient safety” CMEs), and quality…

    Read More

  • Glucose Before Thiamine In Hypoglycemia

    Glucose Before Thiamine In Hypoglycemia

    “Thiamine before glucose” is a bedside teaching that started with a sound physiologic concept and slowly hardened into dogma when dealing with patients with alcohol use disorder. Thiamine deficiency underlies Wernicke encephalopathy, a preventable but often missed neurologic emergency most commonly seen in alcohol use disorder, malnutrition, prolonged vomiting, and…

    Read More

  • iRhythm Zio AT Cardiac Monitor

    iRhythm Zio AT Cardiac Monitor

    Premature atrial complexes (PACs) are something I’ve explained to trainees and patients for years, but about a week ago, I started having them following a really rough stretch in the CVICU. As a cardiac anesthesiologist and intensivist, I know how common PACs are and how often they are benign, but…

    Read More

  • Left Ventricular (LV) Thrombus

    Left Ventricular (LV) Thrombus

    Left ventricular (LV) thrombus is typically a result of stasis from myocardial hypokinesis/akinesis. A segment of myocardium stops moving, blood lingers in the cul-de-sac of an akinetic apex, and the endocardial surface becomes a scaffold for clot. Large anterior infarctions, end-stage heart failure, and dilated ventricles can set the stage…

    Read More

  • High Altitude Pulmonary Edema (HAPE)

    High Altitude Pulmonary Edema (HAPE)

    High altitude pulmonary edema (HAPE) typically shows up in otherwise healthy patients after rapid ascent (e.g., mountain-climbing) with subsequent coughing, tachycardia, hypoxemia, and fatigue. These symptoms are often attributed to overexertion or dehydration, but it’s important to recognize the underlying physiology. At its core, altitude exposes the lung to hypoxia…

    Read More

  • Olanzapine Versus Quetiapine In The ICU

    Olanzapine Versus Quetiapine In The ICU

    Olanzapine (Zyprexa) and quetiapine (Seroquel) are often discussed as if they are interchangeable sedating antipsychotics used to help with addressing facets of delirium (insomnia, emotional lability, etc.). It often feels like dealer’s choice when deciding which one to use. Here are some of my considerations as an intensivist. Olanzapine is…

    Read More

  • Andexxa Off The US Market

    Andexxa Off The US Market

    Andexanet alfa (Andexxa) will leave the US market on December 22, 2025, after AstraZeneca withdrew its biologics license application for commercial reasons. For a drug that costs as much as a car (~$25-50K per dose) and carries meaningful safety concerns… good riddance! Andexanet entered practice as the only FDA-approved reversal…

    Read More